BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Gut-liver axis
1
Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption?
12/26/2025 10:27:35 AM | Browse: 61 | Download: 190
2
Gluten’s silent strike: Unmasking its impact on liver health
12/22/2025 7:43:02 AM | Browse: 51 | Download: 174
3
Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention
12/19/2025 8:32:39 AM | Browse: 107 | Download: 259
4
Tumor-resident microorganisms as clinical biomarkers in primary liver cancer: A systematic review of current evidence
12/11/2025 8:20:56 AM | Browse: 96 | Download: 259
5
Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond
12/5/2025 11:28:03 AM | Browse: 84 | Download: 264
6
Uridine diphosphate-glucose 6-dehydrogenase-mediated glucuronidation and its emerging role in gut-liver immune regulation
10/14/2025 7:42:32 AM | Browse: 56 | Download: 195
7
Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies
10/11/2025 9:30:02 AM | Browse: 71 | Download: 317
8
Unraveling the gut-liver axis in autoimmune liver disease overlap syndrome: A multi-omics perspective
9/25/2025 3:33:09 AM | Browse: 168 | Download: 271
9
Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities
8/5/2025 8:25:47 AM | Browse: 117 | Download: 268
10
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
6/26/2025 7:27:54 AM | Browse: 178 | Download: 599
11
Gut feeling gone wrong: Tangled relationship between disorders of gut-brain interaction and liver disease
5/27/2025 7:04:47 AM | Browse: 87 | Download: 442
12
Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, feces in hepatocellular carcinoma
5/15/2025 10:28:56 AM | Browse: 140 | Download: 608
13
Potential mechanisms and therapeutic prospects of the association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis
1/6/2025 8:47:55 AM | Browse: 171 | Download: 807
14
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy
10/31/2024 10:42:49 AM | Browse: 101 | Download: 443
15
Sepsis-associated liver injury: Mechanisms and potential therapeutic targets
10/31/2024 10:39:35 AM | Browse: 165 | Download: 647
16
Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications and therapeutic potentials
10/25/2024 3:02:14 AM | Browse: 144 | Download: 751
17
Importance of the gut microbiota in the gut-liver axis in normal and liver disease
6/20/2024 3:42:22 AM | Browse: 224 | Download: 783
18
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis
5/22/2024 11:33:24 AM | Browse: 232 | Download: 958
19
Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions
3/6/2024 6:10:51 AM | Browse: 328 | Download: 822
20
Epidemiology of small intestinal bacterial overgrowth
6/7/2023 6:39:13 AM | Browse: 572 | Download: 954
21
Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
3/17/2023 6:20:53 AM | Browse: 440 | Download: 1028
22
Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
1/4/2023 5:53:01 AM | Browse: 474 | Download: 1424
23
Intestinal microbiota in the treatment of metabolically associated fatty liver disease
10/27/2022 4:55:04 AM | Browse: 608 | Download: 1241
24
Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
8/26/2022 9:51:35 AM | Browse: 628 | Download: 1754
25
Gut dysbiosis and body composition in cirrhosis
6/23/2022 2:39:01 PM | Browse: 798 | Download: 2610
26
Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
3/11/2022 9:47:59 AM | Browse: 718 | Download: 2284
27
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
2/22/2022 9:25:37 AM | Browse: 729 | Download: 1903
28
Overview of the microbiota in the gut-liver axis in viral B and C hepatitis
11/19/2021 11:15:33 AM | Browse: 668 | Download: 1410
29
Probiotics in hepatology: An update
9/22/2021 8:09:41 AM | Browse: 874 | Download: 2010
30
Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
8/5/2021 2:37:04 PM | Browse: 727 | Download: 2069
31
Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
5/20/2021 3:14:20 PM | Browse: 950 | Download: 2665
32
Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
5/10/2021 7:46:10 AM | Browse: 826 | Download: 2643
33
Role of gut microbiota <Italic>via</Italic> the gut-liver-brain axis in digestive diseases
10/28/2020 8:26:09 AM | Browse: 823 | Download: 2081
34
Gut-liver axis signaling in portal hypertension
10/21/2019 9:37:00 AM | Browse: 1163 | Download: 2681
35
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
9/7/2019 4:43:36 AM | Browse: 1262 | Download: 2572
36
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
1/26/2019 11:40:14 AM | Browse: 1386 | Download: 3042
37
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
12/2/2015 12:01:00 PM | Browse: 1724 | Download: 2238
38
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
11/17/2014 3:13:00 PM | Browse: 1529 | Download: 1773
39
Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection
10/29/2014 7:34:00 PM | Browse: 1258 | Download: 1867